Skip to main content

noComment
Deadly strain of bird flu confirmed in Turkey

world news

| |

The bird flu virus that has spread to Turkey has been confirmed as the H5N1 strain that is dangerous to humans. There is no anti-viral drug available specifically for this disease, although the EU says other products could be effective.

European Commissioner for health Markos Kyprianou said: “We have received now confirmation that the virus found in Turkey is an avain flu H5N1 high pathogenic virus.” “Our experts team which was on location in Romania performed some tests with our reagents and it was confirmed again that it was the H5 virus. We don’t know the rest of the strain, we don’t know if it was the one in Turkey.” Kyprianou said migratory birds could transmit the virus. The news confirms that potentially lethal bird flu, which has killed more than 60 people in Asia since 2003, has reached southeastern Europe. The Commission says it is working on the assumption that the strain found in Romania is the deadly version. There authorities plan to cull 15,000 birds. EU experts on avian influenza and migratory birds will hold an emergency meeting on Friday. They are expected to advise precautions to be taken in Romania and Turkey, including asking travellers to avoid visiting farms.

Copyright © 2012 euronews

| |

Top Stories

Syrian bloodshed spreads to Aleppo

Syrian bloodshed spreads to Aleppo

The upsurge in violence in Syria has spread to the northern city of Aleppo, where soldiers and civilians have been killed in separate explosions, according to state TV. It said a building used by military intelligence and a security forces as a base, had been targeted in what it described as…

Tahrir marks the anniversary of Mubarak's ouster

Tahrir marks the anniversary of Mubarak's ouster Egypt is braced for a general strike on Saturday, the day which marks the one year anniversary of…

Login

Please enter your login details

Join the euronews community

By joining euronews’ community , you can participate to U talk and I talk and subscribe to our newsletters.
Please note: All fields are required